Galmed Pharmaceuticals Ltd
Clinical trials sponsored by Galmed Pharmaceuticals Ltd, explained in plain language.
Galmed Pharmaceuticals Ltd
GLMD
NASDAQ
A clinical-stage biopharmaceutical company developing therapies for liver diseases, including NASH.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.